We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Qlucore Receives European Funding That will Benefit Personalized Medicine

News   Sep 05, 2013

 
Qlucore Receives European Funding That will Benefit Personalized Medicine
 
 
 

RELATED ARTICLES

World First: Genetically Engineered Moth Is Released Into an Open Field

News

For the first time scientists have released a genetically engineered, self-limiting agricultural pest into an open field. They have evaluated its potential for future crop protection, with promising results.

READ MORE

Unanticipated Response to Estrogen at the Single Cell Level

News

A new study suggests that not only do individual mammalian cells in a population fail to respond synchronously to estrogen stimulation, neither do individual alleles.

READ MORE

Gene Therapy for Duchenne Muscular Dystrophy Successful in Pigs

News

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE